CRISPR/Cas9 and base editors mediated genome editing methods have been developed and carried great hope for the treatment of genetic diseases induced by pathogenic mutations (1) (2) (3) (4) (5) (6). Clinical applications of CRISPR/Cas9-based genome editing or base editors require a comprehensive analysis of off-target effects to minimize risk of deleterious mutations, but a well validated method robust to genetic variants is undescribed yet to detect SNVs (7). Multiple methods have been developed to detect genome-wide gene-editing off-target activity in cells, including high-throughput genome-wide translocation sequencing (HTGTS) (8), genome-wide, unbiased identification of doublestrand breaks (GUIDE-seq) (9) and circularization for in vitro reporting of cleavage effects by sequencing (CIRCLE-seq) (10).
However, these approaches are not applicable to detect SNVs.
Thereafter, GOTI was developed and applied to evaluate the offtarget effects induced by CRISPR/Cas9 or BE3 (rAPOBEC1-nCas9-UGI), the commonly used gene editing tools (4, 11) . Briefly, we performed either CRISPR/Cas9 or BE3 gene editing, together with Cre mRNA, in one blastomere of the two-cell embryos derived from Ai9 (CAG-LoxP-Stop-LoxP-tdTomato) mice (12, 13) (Fig. 1a) .
The progeny cells of edited and non-edited blastomeres were then sorted at E14.5 by fluorescence-activated cell sorting (FACS), In addition, we verified the editing efficiency of our approach on the targeted Tyr gene. For genome-wide sequencing studies using the embryo injection protocol, we included four sgRNAs for CRISPR/Cas9 editing: Cas9-Tyr-A and Cas9-Tyr-B targeting at Tyr, one control sgRNA targeting at LacZ without cleavage sites in the C57 mouse genome, and a sgRNA targeting at Pde6b, which has one mismatch with the C57 mouse genome and was previously reported to generate thousands of SNVs (14). We validated the cleavage efficiency of these sgRNAs (~100%) in vitro using DNA cleavage assays ( fig. S2 ). In addition, we examined two sgRNAs (BE3-Tyr-C and BE3-Tyr-D) that targeted Tyr gene via BE3-mediated editing. As control groups for gene editing, we also included three groups of embryos injected with "Cre only", "Cre and Cas9" and "Cre and BE3". (Fig. 1d) . We also analyzed the on-target efficiency for all the other tdTomato + embryos, and found zero on-target editing for all the control embryos (Fig. 1d) .
However, the WGS analysis also revealed a low-level of targeted editing in tdTomato -cells of Cas9-Tyr-A and Cas9-Tyr-B groups in the range of 0 -6.3% (Fig. 1d, fig. S4 These results indicated that the increased SNVs identified were caused by the injection of BE3.
Notably, for the off-targets detected in BE3-treated samples, none of them were shared by any of the embryos in each group (Fig. 2c ), and they were randomly distributed across the genome (Fig. 2d , e, table S10). We then compared these off-target mutations with all the potential off-target sites predicted by both Cas-OFFinder and CRISPROR softwares (tables S11 and S12) (21, 22) . Not surprisingly, the two prediction tools shared a large amount of off-target sites, but none of them were found in our detected SNV sites (Fig. 2f) . Besides, no sequence similarity was observed between adjacent sequences of the identified SNVs and the BE3 sgRNA targeting sites, whereas the top predicted offtarget sites showed sequence similarity with BE3 on-target loci ( Fig. 2g ). Remarkably, in spite of the uniqueness of the SNVs generated by BE3-editing, the mutation types were the same as those preferred by APOBEC1 (23, 24) ( Fig. 2h and fig. S10 ). In fact, more than 90% of the SNVs identified in the BE3-edited cells were mutated from G to A or C to T, which was not observed in
Cre-or CRISPR/Cas9-treated cells ( (Fig. 3b) . We also found 1 SNV in a proto-oncogene and 13
SNVs in tumor suppressors (Fig. 3c) , raising serious concern about the oncogenic risk of BE3-editing.
One of the big advantages of our approach is that rules out genetic background differences by comparing edited to non-edited cells in a single mouse. Previous studies were confounded by genetic background variations when comparing edited and nonedited mice. In fact, we also applied our analysis method to a published dataset (15) and found an average of ~1000 SNVs and ~100 indels between CRISPR/Cas9-edited mice and their nonedited siblings (tables S14). Based on our finding, we suggest that these differences among siblings are due to genetic variations rather than the results of CRISPR/Cas9-editing. Furthermore, when the sequences between any two different embryos in our study were compared, we observed more SNVs (3706 ± 5232) and indels (583 ± 762) (n = 18 pairs), as the embryos used in our study
were not all derived from the same parents (table S15) . These results illustrate that it is difficult to find a robust control in off-target analysis by comparing an edited to non-edited mouse as there is a significant amount of genetic variations between mice even when they have the same parents.
In summary, our studies demonstrate the advantages of GOTI approach using whole-genome sequencing analysis of progeny cells of sister blastomeres in studying off-target effects induced by gene-editing. We also showed that undesired off-target mutations induced by CRISPR/Cas9-mediated gene editing are rare in mouse embryos, supporting previous findings that CRISPR/Cas9-based editing in vivo does not cause significant SNVs and indels (15, (32) (33) (34) 
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Materials and Methods
Mice
Female C57BL/6 mice (4 weeks old) and heterozygous Ai9 (full name B6.CgGt(ROSA)26Sortm9(CAG-td-Tomato)Hze/J; JAX strain 007909) male mice were used for embryo collection. ICR females were used for recipients. The use and care of animals complied with the guideline of the Biomedical Research Ethics Committee of Shanghai
Institutes for Biological Science, Chinese Academy of Sciences.
Generation of Cas9 mRNA, BE3 mRNA, Cre mRNA and sgRNA T7 promoter was added to Cas9 coding region by PCR amplification of px260, using primer Cas9 F and R. T7-Cas9 PCR product was purified and used as the template for in vitro transcription (IVT) using mMESSAGE mMACHINE T7 ULTRA kit (Life Technologies). T7
promoter was added to sgRNA template by PCR amplification of px330. The T7-sgRNA PCR product was purified and used as the template for IVT using MEGA shortscript T7 kit (Life Technologies). T7 promoter was added to Cre template by PCR amplification. T7-Cre PCR product was purified and used as the template for in vitro transcription (IVT) using mMESSAGE mMACHINE T7 ULTRA kit (Life Technologies). Cas9 mRNA, Cre mRNA and sgRNAs were purified using MEGA clear kit (Life Technologies) and eluted in RNase-free water. 
Single-cell PCR Analysis
To pick up and transfer single cells, we used a glass capillary under a dissection microscope.
Eight-cell mouse embryos were digested with acid Tyrode solution to remove the zona pellucida, and then the embryos were transferred into 0.25% trypsin and gently pipetted to separate individual blastomere. Finally, the blastomeres were washed into 0.25% trypsin for 7
to 10 times and transferred into a PCR tube. 1.5 μl lysis buffer containing 0.1% tween 20, 0.1% Triton X-100 and 4 μg/ml proteinase K was then pipetted into the tube. Each tube was centrifuged to facilitate the mix. The lysis was incubated at a temperature of 56°C for 30 min, followed by 95°C for 5 min. The products of the lysis program were used as templates in a nest PCR analysis. All the operations were operated carefully in order not to pollute the samples.
Nest PCR primer 
TA Cloning and Genotyping
The PCR product was purified and ligated to pMD18-T vector and transformed to competent E. coli strain DH5α. After overnight culture at 37 ºC, randomly selected clones were sequenced by the Sanger method. The genotypes of mutant E14.5 embryos were determined by PCR of genomic DNA extracted from cells. ExTaq was activated at 95°C for 3 min, and PCR was performed for 34 cycles at 95°C for 30 sec, 62°C for 30 sec, and 72°C for 1min, with a final extension at 72°C for 5 min. For blastocysts, after washing 6 times with KSOM, the single blastocyst was transferred directly into PCR tubes containing 1.5 μl embryo lysis buffer (0.1% tween 20, 0.1% Triton X-100 and 4 μg/ml proteinase K) and incubate for 30 min at 56˚C, heat inactivate proteinase K at 95˚C for 10 min. PCR amplification was performed using nest primer sets. ExTaq was activated at 95°C for 3 min, and PCR was performed for 34 cycles at 95°C for 30 sec, 62°C for 30 sec, and 72°C for 1min, with a final extension at 72°C for 5 min. Secondary PCR was performed using 0.5 μg primary PCR product and nested inner primer. PCR was carried out in the same reaction mixture. PCR product was gel purified and cloned using pMD-19t cloning kit (Takara) following the manufacturer's instructions. Colonies were picked from each transformation and then Sanger sequencing to detect mutations. The primers used were:
Tyr F GTTATCCTCACACTACTTCTG Tyr R GTAATCCTACCAAGAGTCTCA
Tyr-OF GTCTGTGACACTCATTAACC
Tyr-OR CATAGGAGGTGCTAACAATAC
Tyr-IF GTATTGCCTTCTGTGGAGTT
Tyr-IR TGAACCAATCAGTCCTTGTT
FACS
To isolate cells, the prepared tissues were dissociated enzymatically in an incubation solution of 5 mL Trypsin-EDTA (0.05%) at 37°C for 30min. The digestion was stopped by adding 5 ml of DMEM medium with 10% Fetal Bovine Serum (FBS). Fetal tissues were then homogenized by passing 30-40 times through a 1ml pipette tips. The cell suspension was centrifuged for 6 min (800 rpm), and the pellet was resuspended in DMEM medium with 10% FBS. Finally, the cell suspension was filtered through a 40-μm cell strainer, and tdtomato + /tdtomato -cells were isolated by FACS. Samples were found to be >95% pure when assessed with a second round of flow cytometry and fluorescence microscopy analysis.
Whole genome sequencing and data analysis
Genomic DNA was extracted from cells by using the DNeasy blood and tissue kit (catalog number 69504, Qiagen) according to the manufacturer's instructions. WGS was performed at mean coverages of 50x by Illumina HiSeq X Ten. BWA (v0.7.12) was used to map qualified sequencing reads to the reference genome (mm10). Picard tools (v2.3.0) was then applied to sort and mark duplicates of the mapped BAM files. To identify the genome wide de novo variants with high confidence, we conducted single nucleotide variation calling on three algorithms, Mutect2 (v3.5), Lofreq (v2.1.2) and Strelka (v2.7.1), separately(37-39). In parallel, Mutect2 (v3.5), Scalpel (v0.5.3) and Strelka (v2.7.1) were run individually for the detection of whole genome de novo indels (37, 39, 40) . The overlap of three algorithms of SNVs or indels were considered as the true variants. We also marked variants overlapped with the UCSC repeat regions and microsatellite sequences or existed in the dbSNP (v138) and MGP (v3) databases. All the sequencing data were deposited in NCBI Sequence Read Archive (SRA) under project accession SRP119022.
To validate the on-target efficiency, we blasted the aligned BAM files with the on-target sites with e-value set as 0.0001. Potential off-targets of targeted sites were predicted using two previous reported algorithms, Cas-OFFinder (http://www.rgenome.net/cas-offinder/) and CRISPOR (http://crispor.tefor.net/) with all possible mismatches(21, 22).
The SNVs and indels were annotated with annovar (version 2016-02-01) using RefSeq database(41). Proto-oncogenes and tumor-suppressor genes were retrieved from the UniprotKB/Swiss-Prot database (2018_09). We downloaded five ATAC-seq bed peak files from the CistromeDB database with biological sources as embryonic and passing all quality controls (28). The five datasets retrieved included CistromeDB IDs "79877" (GSM2551659), "79976" (GSM2551677), "80493" (GSM2535470), "81049" (GSM2551664) and "81052" (GSM2551667). The off-target sites were mapped to the peak regions in each bed file based on the chromosome positions, and then the peaks regions with or without the off-targets were compared with each other by two-sided Wilcoxon rank sum test.
Simulation of spontaneous mutations in the development of embryos
To estimate the number of spontaneous mutations from the 2-cell stage to E14.5 stage, the occurrence of single nucleotide mutations was simulated in silico considering the average sequencing coverage of 40 and allele frequency threshold of 10%. For each round of simulation, given the mutation rate of 1.8 x 10 -10 and the size of mouse nuclear genome (2,785,490,220bp), we considered the replication process from the 2-cell stage to 16-cell stage, for mutations occurring after 16-cell stage will not be detected taken the allele frequency into consideration. Each cell may mutate or not during each replication, and once mutation occurs, the divided cells will inherit the mutation. Then the accumulated mutations and their wild-type alleles were randomly selected for sequencing with depth of 40, the selected mutations were summed as the number of spontaneous mutations for each round, and the same process was repeated for 10,000 times.
In vitro cleavage of DNA
The genomic region flanking the sgRNA target site for each gene was PCR amplified and PCR amplicons was purified with the Universal DNA Purification Kit (Tiangen) according to the manufacturer's instructions. Genomic DNA was purified from mice tail with the TIANamp Genomic DNA Kit (Tiangen) according to the manufacturer's instructions. The Cas9 ribonucleoproteins (1 μg) and sgRNA (1 μg) were pre-incubated at room temperature for 10 min to form RNP complexes. DNA (4 μg) was incubated with RNP complexes in a reaction buffer for 3 h at 37°C. Digested DNA was purified again with Universal DNA Purification Kit (Tiangen) after RNase A (100 μg/ml) was added to remove sgRNA.
Digenome sequencing analysis
Libraries were subjected to WGS using Illumina HiSeq X Ten sequencer and the WGS was performed at a sequencing depth of 30x to 40x. Qualified reads were aligned to the mouse reference genome (mm10) by Isaac aligner with the following parameters: base quality cutoff, 15; keep duplicate reads, yes; variable read length support, yes; realign gaps, no. DNA cleavage sites were identified computationally using Digenome-seq2
(https://github.com/chizksh/digenome-toolkit2).
Statistical analysis
R version 3.5.1 (http://www.R-project.org/ ) was used to conduct all the statistical analyses in this work. All tests conducted were two-sided, and the significant difference was considered at P < 0.05.
